Rapid extraction of viral DNA or RNA from plasma, serum, urine, ascites, cell culture fluid, supernatant, cell-free body fluid, can be used in various common downstream experiments, such as restriction digestion, reverse transcription, etc.
The global Molecular Laboratory Diagnostic Kits market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淢olecular Laboratory Diagnostic Kits Industry Forecast鈥� looks at past sales and reviews total world Molecular Laboratory Diagnostic Kits sales in 2023, providing a comprehensive analysis by region and market sector of projected Molecular Laboratory Diagnostic Kits sales for 2024 through 2030. With Molecular Laboratory Diagnostic Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Laboratory Diagnostic Kits industry.
This Insight Report provides a comprehensive analysis of the global Molecular Laboratory Diagnostic Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Laboratory Diagnostic Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Molecular Laboratory Diagnostic Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Laboratory Diagnostic Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Laboratory Diagnostic Kits.
The global medical device market is estimated to be US$603.3 billion in 2023, with a compound annual growth rate of 5% expected in the next six years. Global health care expenditure currently accounts for approximately 10% of global GDP, and the proportion will continue to increase in the next few years. This is primarily due to the increasing demand for healthcare from an aging population, the rising prevalence of chronic and infectious diseases, and the expansion of emerging markets. The medical device market plays an important role in the healthcare spending industry. The medical device market is driven by a variety of factors, including increasing global demand for advanced medical services, advancements in medical technology, growing geriatric population, increasing medical expenditures, and increasing awareness of early stage disease diagnosis and treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Laboratory Diagnostic Kits market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Infectious Disease
Respiratory Disease
Gastrointestinal Disease
Others
Segmentation by Application:
Hospital
Clinic
Research Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Seegene
SPACEGEN
VITASSAY HEALTHCARE S.L.
Yaneng Bioscience (Shenzhen) Co., Ltd.
Zhejiang Orient Gene
ELITech Group
Fujirebio
Jiangsu Bioperfectus Technologies Co., Ltd.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
Altona Diagnostics GmbH
NZYTech
ATTOPLEX
OSANG Healthcare
Panagene Inc.
PCRmax
R-Biopharm AG
AB Analitica
Celnovte Biotechnology Co., Ltd.
Elisabeth Pharmacon Spol
Jiangsu Mole Bioscience CO., LTD.
Medical Innovation Ventures
Randox Laboratories
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molecular Laboratory Diagnostic Kits market?
What factors are driving Molecular Laboratory Diagnostic Kits market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molecular Laboratory Diagnostic Kits market opportunities vary by end market size?
How does Molecular Laboratory Diagnostic Kits break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Laboratory Diagnostic Kits Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Molecular Laboratory Diagnostic Kits by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Molecular Laboratory Diagnostic Kits by Country/Region, 2019, 2023 & 2030
2.2 Molecular Laboratory Diagnostic Kits Segment by Type
2.2.1 Infectious Disease
2.2.2 Respiratory Disease
2.2.3 Gastrointestinal Disease
2.2.4 Others
2.3 Molecular Laboratory Diagnostic Kits Sales by Type
2.3.1 Global Molecular Laboratory Diagnostic Kits Sales Market Share by Type (2019-2024)
2.3.2 Global Molecular Laboratory Diagnostic Kits Revenue and Market Share by Type (2019-2024)
2.3.3 Global Molecular Laboratory Diagnostic Kits Sale Price by Type (2019-2024)
2.4 Molecular Laboratory Diagnostic Kits Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Center
2.4.4 Others
2.5 Molecular Laboratory Diagnostic Kits Sales by Application
2.5.1 Global Molecular Laboratory Diagnostic Kits Sale Market Share by Application (2019-2024)
2.5.2 Global Molecular Laboratory Diagnostic Kits Revenue and Market Share by Application (2019-2024)
2.5.3 Global Molecular Laboratory Diagnostic Kits Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Molecular Laboratory Diagnostic Kits Breakdown Data by Company
3.1.1 Global Molecular Laboratory Diagnostic Kits Annual Sales by Company (2019-2024)
3.1.2 Global Molecular Laboratory Diagnostic Kits Sales Market Share by Company (2019-2024)
3.2 Global Molecular Laboratory Diagnostic Kits Annual Revenue by Company (2019-2024)
3.2.1 Global Molecular Laboratory Diagnostic Kits Revenue by Company (2019-2024)
3.2.2 Global Molecular Laboratory Diagnostic Kits Revenue Market Share by Company (2019-2024)
3.3 Global Molecular Laboratory Diagnostic Kits Sale Price by Company
3.4 Key Manufacturers Molecular Laboratory Diagnostic Kits Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Laboratory Diagnostic Kits Product Location Distribution
3.4.2 Players Molecular Laboratory Diagnostic Kits Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Molecular Laboratory Diagnostic Kits by Geographic Region
4.1 World Historic Molecular Laboratory Diagnostic Kits Market Size by Geographic Region (2019-2024)
4.1.1 Global Molecular Laboratory Diagnostic Kits Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Molecular Laboratory Diagnostic Kits Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Molecular Laboratory Diagnostic Kits Market Size by Country/Region (2019-2024)
4.2.1 Global Molecular Laboratory Diagnostic Kits Annual Sales by Country/Region (2019-2024)
4.2.2 Global Molecular Laboratory Diagnostic Kits Annual Revenue by Country/Region (2019-2024)
4.3 Americas Molecular Laboratory Diagnostic Kits Sales Growth
4.4 APAC Molecular Laboratory Diagnostic Kits Sales Growth
4.5 Europe Molecular Laboratory Diagnostic Kits Sales Growth
4.6 Middle East & Africa Molecular Laboratory Diagnostic Kits Sales Growth
5 Americas
5.1 Americas Molecular Laboratory Diagnostic Kits Sales by Country
5.1.1 Americas Molecular Laboratory Diagnostic Kits Sales by Country (2019-2024)
5.1.2 Americas Molecular Laboratory Diagnostic Kits Revenue by Country (2019-2024)
5.2 Americas Molecular Laboratory Diagnostic Kits Sales by Type (2019-2024)
5.3 Americas Molecular Laboratory Diagnostic Kits Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Laboratory Diagnostic Kits Sales by Region
6.1.1 APAC Molecular Laboratory Diagnostic Kits Sales by Region (2019-2024)
6.1.2 APAC Molecular Laboratory Diagnostic Kits Revenue by Region (2019-2024)
6.2 APAC Molecular Laboratory Diagnostic Kits Sales by Type (2019-2024)
6.3 APAC Molecular Laboratory Diagnostic Kits Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Molecular Laboratory Diagnostic Kits by Country
7.1.1 Europe Molecular Laboratory Diagnostic Kits Sales by Country (2019-2024)
7.1.2 Europe Molecular Laboratory Diagnostic Kits Revenue by Country (2019-2024)
7.2 Europe Molecular Laboratory Diagnostic Kits Sales by Type (2019-2024)
7.3 Europe Molecular Laboratory Diagnostic Kits Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Laboratory Diagnostic Kits by Country
8.1.1 Middle East & Africa Molecular Laboratory Diagnostic Kits Sales by Country (2019-2024)
8.1.2 Middle East & Africa Molecular Laboratory Diagnostic Kits Revenue by Country (2019-2024)
8.2 Middle East & Africa Molecular Laboratory Diagnostic Kits Sales by Type (2019-2024)
8.3 Middle East & Africa Molecular Laboratory Diagnostic Kits Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molecular Laboratory Diagnostic Kits
10.3 Manufacturing Process Analysis of Molecular Laboratory Diagnostic Kits
10.4 Industry Chain Structure of Molecular Laboratory Diagnostic Kits
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molecular Laboratory Diagnostic Kits Distributors
11.3 Molecular Laboratory Diagnostic Kits Customer
12 World Forecast Review for Molecular Laboratory Diagnostic Kits by Geographic Region
12.1 Global Molecular Laboratory Diagnostic Kits Market Size Forecast by Region
12.1.1 Global Molecular Laboratory Diagnostic Kits Forecast by Region (2025-2030)
12.1.2 Global Molecular Laboratory Diagnostic Kits Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Molecular Laboratory Diagnostic Kits Forecast by Type (2025-2030)
12.7 Global Molecular Laboratory Diagnostic Kits Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Seegene
13.1.1 Seegene Company Information
13.1.2 Seegene Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.1.3 Seegene Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Seegene Main Business Overview
13.1.5 Seegene Latest Developments
13.2 SPACEGEN
13.2.1 SPACEGEN Company Information
13.2.2 SPACEGEN Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.2.3 SPACEGEN Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 SPACEGEN Main Business Overview
13.2.5 SPACEGEN Latest Developments
13.3 VITASSAY HEALTHCARE S.L.
13.3.1 VITASSAY HEALTHCARE S.L. Company Information
13.3.2 VITASSAY HEALTHCARE S.L. Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.3.3 VITASSAY HEALTHCARE S.L. Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 VITASSAY HEALTHCARE S.L. Main Business Overview
13.3.5 VITASSAY HEALTHCARE S.L. Latest Developments
13.4 Yaneng Bioscience (Shenzhen) Co., Ltd.
13.4.1 Yaneng Bioscience (Shenzhen) Co., Ltd. Company Information
13.4.2 Yaneng Bioscience (Shenzhen) Co., Ltd. Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.4.3 Yaneng Bioscience (Shenzhen) Co., Ltd. Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Yaneng Bioscience (Shenzhen) Co., Ltd. Main Business Overview
13.4.5 Yaneng Bioscience (Shenzhen) Co., Ltd. Latest Developments
13.5 Zhejiang Orient Gene
13.5.1 Zhejiang Orient Gene Company Information
13.5.2 Zhejiang Orient Gene Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.5.3 Zhejiang Orient Gene Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Zhejiang Orient Gene Main Business Overview
13.5.5 Zhejiang Orient Gene Latest Developments
13.6 ELITech Group
13.6.1 ELITech Group Company Information
13.6.2 ELITech Group Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.6.3 ELITech Group Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 ELITech Group Main Business Overview
13.6.5 ELITech Group Latest Developments
13.7 Fujirebio
13.7.1 Fujirebio Company Information
13.7.2 Fujirebio Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.7.3 Fujirebio Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Fujirebio Main Business Overview
13.7.5 Fujirebio Latest Developments
13.8 Jiangsu Bioperfectus Technologies Co., Ltd.
13.8.1 Jiangsu Bioperfectus Technologies Co., Ltd. Company Information
13.8.2 Jiangsu Bioperfectus Technologies Co., Ltd. Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.8.3 Jiangsu Bioperfectus Technologies Co., Ltd. Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Jiangsu Bioperfectus Technologies Co., Ltd. Main Business Overview
13.8.5 Jiangsu Bioperfectus Technologies Co., Ltd. Latest Developments
13.9 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
13.9.1 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Information
13.9.2 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.9.3 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Main Business Overview
13.9.5 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Latest Developments
13.10 Altona Diagnostics GmbH
13.10.1 Altona Diagnostics GmbH Company Information
13.10.2 Altona Diagnostics GmbH Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.10.3 Altona Diagnostics GmbH Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Altona Diagnostics GmbH Main Business Overview
13.10.5 Altona Diagnostics GmbH Latest Developments
13.11 NZYTech
13.11.1 NZYTech Company Information
13.11.2 NZYTech Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.11.3 NZYTech Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 NZYTech Main Business Overview
13.11.5 NZYTech Latest Developments
13.12 ATTOPLEX
13.12.1 ATTOPLEX Company Information
13.12.2 ATTOPLEX Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.12.3 ATTOPLEX Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 ATTOPLEX Main Business Overview
13.12.5 ATTOPLEX Latest Developments
13.13 OSANG Healthcare
13.13.1 OSANG Healthcare Company Information
13.13.2 OSANG Healthcare Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.13.3 OSANG Healthcare Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 OSANG Healthcare Main Business Overview
13.13.5 OSANG Healthcare Latest Developments
13.14 Panagene Inc.
13.14.1 Panagene Inc. Company Information
13.14.2 Panagene Inc. Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.14.3 Panagene Inc. Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Panagene Inc. Main Business Overview
13.14.5 Panagene Inc. Latest Developments
13.15 PCRmax
13.15.1 PCRmax Company Information
13.15.2 PCRmax Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.15.3 PCRmax Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 PCRmax Main Business Overview
13.15.5 PCRmax Latest Developments
13.16 R-Biopharm AG
13.16.1 R-Biopharm AG Company Information
13.16.2 R-Biopharm AG Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.16.3 R-Biopharm AG Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 R-Biopharm AG Main Business Overview
13.16.5 R-Biopharm AG Latest Developments
13.17 AB Analitica
13.17.1 AB Analitica Company Information
13.17.2 AB Analitica Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.17.3 AB Analitica Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 AB Analitica Main Business Overview
13.17.5 AB Analitica Latest Developments
13.18 Celnovte Biotechnology Co., Ltd.
13.18.1 Celnovte Biotechnology Co., Ltd. Company Information
13.18.2 Celnovte Biotechnology Co., Ltd. Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.18.3 Celnovte Biotechnology Co., Ltd. Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Celnovte Biotechnology Co., Ltd. Main Business Overview
13.18.5 Celnovte Biotechnology Co., Ltd. Latest Developments
13.19 Elisabeth Pharmacon Spol
13.19.1 Elisabeth Pharmacon Spol Company Information
13.19.2 Elisabeth Pharmacon Spol Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.19.3 Elisabeth Pharmacon Spol Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Elisabeth Pharmacon Spol Main Business Overview
13.19.5 Elisabeth Pharmacon Spol Latest Developments
13.20 Jiangsu Mole Bioscience CO., LTD.
13.20.1 Jiangsu Mole Bioscience CO., LTD. Company Information
13.20.2 Jiangsu Mole Bioscience CO., LTD. Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.20.3 Jiangsu Mole Bioscience CO., LTD. Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Jiangsu Mole Bioscience CO., LTD. Main Business Overview
13.20.5 Jiangsu Mole Bioscience CO., LTD. Latest Developments
13.21 Medical Innovation Ventures
13.21.1 Medical Innovation Ventures Company Information
13.21.2 Medical Innovation Ventures Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.21.3 Medical Innovation Ventures Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Medical Innovation Ventures Main Business Overview
13.21.5 Medical Innovation Ventures Latest Developments
13.22 Randox Laboratories
13.22.1 Randox Laboratories Company Information
13.22.2 Randox Laboratories Molecular Laboratory Diagnostic Kits Product Portfolios and Specifications
13.22.3 Randox Laboratories Molecular Laboratory Diagnostic Kits Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Randox Laboratories Main Business Overview
13.22.5 Randox Laboratories Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
